Eye Movement Desensitization (EMD) to reduce posttraumatic stress disorder-related stress reactivity: a study protocol for a randomized controlled trial

BUDI LN_LPDP (Indonesian Scholarship)0 个研究点目标入组 91 人开始时间: 2017年12月19日最近更新: 2022年5月30日

适应症

试验速览

2021 Protocol article in https://pubmed.ncbi.nlm.nih.gov/33663549/ protocol (added 05/03/2021) 2022 Results article in https://pubmed.ncbi.nlm.nih.gov/35548495/ (added 16/05/2022)

•Current inclusion criteria as of 14/01/2020:
•1. Diagnostic and Statistical Manual of Mental Disorder, fifth edition (DSM-5) diagnosis of PTSD as diagnosed with the Structured Clinical Interview for DSM-5 disorders (SCID-5)
•2. Age of 18 years or older
•______
•Previous inclusion criteria:
•1. Individuals who were either diagnosed posttraumatic stress disorder (PTSD) by a professional, i.e., by a clinical psychologist and meet DSM-V-TR, the diagnostic rule which requires at least one criteria of A, B, and C and at least two criteria of D and E and with cut off 33 of PCL-5 score
•2. Suffering from posttraumatic stress symptoms on a subclinical level with one symptom in each criterion of PTSD symptoms and with cut off 20 of PCL-5 score
•3. Minimal age of 18 years

•Current inclusion criteria as of 14/01/2020:
•1. Current or previous psychotic disorder
•2. Current substance use disorder
•3. Acute suicidality
•4. Current organic disorder i.e. epileptic, brain damage
•Previous exclusion criteria:
•1. Individuals with current organic disorders, psychotic disorders, substance abuse, or suicidal ideation will be excluded
•2. Individuals that are currently taking any medication for psychological or psychiatric disorders are excluded

发起方

BUDI LN_LPDP (Indonesian Scholarship)